Clinical Safety and Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell Transplantation in Sensorineural Hearing Loss Patients
Journal of Audiology & Otology
;
: 105-109, 2018.
Artículo
en Inglés
| WPRIM
| ID: wpr-740320
ABSTRACT
Stem cell transplantation represents a promising therapy for several degenerating and necrotic diseases. In several animal studies, we could find hearing restoration after inoculation of the mesenchymal stem cells' as well as mesenchymal stem cells' differentiation of hair cells and spiral ganglion. But until now, no clinical study has been reported directly for the human being. In this pilot studies, we applied mesenchymal stem cells to human beings trans-venously. Although we verified the safety of the autologous bone marrow stem cell transplantation in sensorineural hearing loss patients but we could not achieve significant improvement in hearing.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Médula Ósea
/
Proyectos Piloto
/
Ganglio Espiral de la Cóclea
/
Trasplante de Células Madre
/
Trasplante de Células Madre Mesenquimatosas
/
Estimulación Eléctrica
/
Células Madre Mesenquimatosas
/
Estudio Clínico
/
Cabello
/
Audición
Límite:
Animales
/
Humanos
Idioma:
Inglés
Revista:
Journal of Audiology & Otology
Año:
2018
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS